[go: up one dir, main page]

BRPI0002694C1 - process of obtaining rabies vaccine in vero cells for human use - Google Patents

process of obtaining rabies vaccine in vero cells for human use

Info

Publication number
BRPI0002694C1
BRPI0002694C1 BRPI0002694A BR0002694A BRPI0002694C1 BR PI0002694 C1 BRPI0002694 C1 BR PI0002694C1 BR PI0002694 A BRPI0002694 A BR PI0002694A BR 0002694 A BR0002694 A BR 0002694A BR PI0002694 C1 BRPI0002694 C1 BR PI0002694C1
Authority
BR
Brazil
Prior art keywords
vero cells
obtaining
human use
rabies vaccine
vaccine
Prior art date
Application number
BRPI0002694A
Other languages
Portuguese (pt)
Other versions
BRPI0002694B8 (en
BR0002694A (en
BRPI0002694B1 (en
Inventor
Maria Frazatti Gallina Neuza
Original Assignee
Fund Butantan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund Butantan filed Critical Fund Butantan
Priority to BRPI0002694A priority Critical patent/BRPI0002694C1/en
Publication of BR0002694A publication Critical patent/BR0002694A/en
Publication of BRPI0002694B1 publication Critical patent/BRPI0002694B1/en
Publication of BRPI0002694B8 publication Critical patent/BRPI0002694B8/en
Publication of BRPI0002694C1 publication Critical patent/BRPI0002694C1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"processo de obtenção de vacina contra raiva em células vero, para uso humano". o qual prevê a utilização de um meio de cultura livre de proteinas de origem animal ou humana (vp-sfm) na produção de suspensões de vírus rábico em células vero aderidas a microcarregadores e cultivadas em biorreator, bem como prevê a purificação do concentrado viral vacinal através de uma resina que reduz a zero o dna celular residual."Process of obtaining a vaccine against rabies in vero cells, for human use". which provides for the use of a culture medium free of proteins of animal or human origin (vp-sfm) in the production of rabies virus suspensions in vero cells adhered to microcarriers and cultivated in a bioreactor, as well as providing for the purification of the vaccine viral concentrate through a resin that reduces the residual cellular DNA to zero.

BRPI0002694A 2000-06-19 2000-06-19 process of obtaining rabies vaccine in vero cells for human use BRPI0002694C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0002694A BRPI0002694C1 (en) 2000-06-19 2000-06-19 process of obtaining rabies vaccine in vero cells for human use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0002694A BRPI0002694C1 (en) 2000-06-19 2000-06-19 process of obtaining rabies vaccine in vero cells for human use

Publications (4)

Publication Number Publication Date
BR0002694A BR0002694A (en) 2002-02-19
BRPI0002694B1 BRPI0002694B1 (en) 2015-08-04
BRPI0002694B8 BRPI0002694B8 (en) 2015-09-22
BRPI0002694C1 true BRPI0002694C1 (en) 2021-05-25

Family

ID=3944558

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0002694A BRPI0002694C1 (en) 2000-06-19 2000-06-19 process of obtaining rabies vaccine in vero cells for human use

Country Status (1)

Country Link
BR (1) BRPI0002694C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060110406A1 (en) 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
AU2004263813B8 (en) 2003-02-25 2008-09-11 Medimmune, Llc Methods of producing influenza vaccine compositions

Also Published As

Publication number Publication date
BRPI0002694B8 (en) 2015-09-22
BR0002694A (en) 2002-02-19
BRPI0002694B1 (en) 2015-08-04

Similar Documents

Publication Publication Date Title
ATE482267T1 (en) ANIMAL CELLS AND METHODS FOR REPLICATION OF INFLUENZA VIRUSES
BRPI0407636A (en) cell culture medium, animal cell lineage, methods for producing a conditioned culture medium, animal cells, an animal cell culture, virus in an animal cell culture, or preferably anchor-dependent diploid human, method for produce a vaccine, and virus population
DE69535560D1 (en) A REINFORCED, VIRUS-RELATED DNA TRANSFER
ATE289348T1 (en) METHODS OF INCREASE VIRAL VACCINE PRODUCTION IN CELL CULTURE BY SUPPRESSING INTERFERON
FR08C0046I2 (en) IN VITRO RECONSTRUCTION OF SEGMENTED POLARITY-NEGATIVE RNA VIRUSES
YU17891A (en) DNA RESPONSIBLE TO THE GENOME OF A RNA NEGATIVE CHAIN VIRUS, AND A PROCEDURE FOR OBTAINING INFECTIOUS RNAEES WITH A NEGATIVE RNA CHAIN
MX2007005132A (en) Animal protein-free media for cultivation of cells.
PT891420E (en) PROCESSES FOR THE REPLICATION OF INFLUENZA VIRUSES IN A CELLULAR CULTURE AND THE INFLUENZA VIRUS THAT CAN BE OBTAINED THROUGH THE PROCESS
ATE479742T1 (en) METHOD FOR THE LARGE-SCALE PRODUCTION OF VACCINES
YU45871B (en) POLYPEPTIDE WITH HUMAN IMMUNOINTERFERON (IFN-GAMMA) PROPERTIES
ATE460473T1 (en) IMMORTALIZED ENT CELL LINES FOR VIRUS GENERATION
ATE469972T1 (en) MULTIPLASMID SYSTEM FOR GENERATING THE FLU VIRUS
ATE325533T1 (en) METHOD FOR IMPROVED VIRUS-MEDIATED DNA TRANSFER USING MOLECULES WITH VIRUS AND CELL-BINDING DOMAIN
CL2008003794A1 (en) Genetically modified vesicular stomatitis virus (vsv) comprising at least one amino acid mutation in a region of some of the m, g and l proteins of the virus; method to produce it; immunogenic composition comprising it; method of adapting a virus in a cell culture.
CY1107431T1 (en) PARTICLES FOR GONAL TREATMENT
BRPI0002694C1 (en) process of obtaining rabies vaccine in vero cells for human use
BRPI0914805B8 (en) method for replicating virus in scldk cell culture, process for adapting substrate-dependent cldk cells for growth in suspension, method for continuously propagating scldk cells in suspension, and composition
BR0014666A (en) Vaccine
DK1334197T3 (en) Yeast-derived vaccine against IPNV
EP1517987A4 (en) LUNG CELLS OF COTTON RATES TO VIRUS CULTURE
ATE464375T1 (en) METHOD FOR PRODUCING VIRUS MATERIAL
EP1739167A4 (en) METHOD OF PRODUCING VIRUSES
Arella et al. Protein synthesis in a Lymantria dispar cell line infected by cytoplasmic polyhedrosis virus
CA2250714A1 (en) Animal cells and processes for the replication of influenza viruses
BRPI0400341A (en) Process for obtaining purified bhk-21 cell rabies vaccine for veterinary use and its resulting vaccine

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/08/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: REFERENTE AO DESPACHO 16.1 PUBLICADO NA RPI 2326

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/06/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Expiry acc. art. 78, item i of ipl- expiry of the term of protection

Free format text: PATENTE EXTINTA EM 19/06/2020